Previous 10 | Next 10 |
2023-10-20 14:18:40 ET Penny stocks have not been as popular as you might think over the last few weeks. Thanks to plenty of economic uncertainty and concerns over inflation, investors have pulled back on risk. However, that doesn’t mean traders are dealing the same. Anyone who...
2023-08-31 06:24:00 ET 3 Things To Use to Become a Successful Penny Stocks Trader Trading penny stocks has garnered significant attention in recent years, primarily due to their potential for substantial returns on investment. At their core, penny stocks are shares of companies that...
2023-08-31 03:30:52 ET Summary Baker Brothers' 13F portfolio value decreased from $18.38B to $17.28B. The largest five stakes in the portfolio are Seagen, Incyte, BeiGene, ACADIA Pharmaceuticals, and Madrigal Pharmaceuticals, making up around 83% of the portfolio. Baker Brothe...
2023-08-30 13:16:02 ET Gainers: NanoVibronix ( NAOV ) +127% . iCoreConnect ( ICCT ) +49% . Aravive ( ARAV ) +35% . AEON Biopharma ( AEON ) +33% . Alarum Technologies ( ALAR ) +25% . Greenland Technologies Holding Corporation ...
2023-08-22 16:09:27 ET Aravive sinks amid downgrades after Phase 3 setback for lead asset Aravive stock pops on FDA orphan drug status for batiraxcept to treat pancreatic cancer Aravive gains on FDA Fast Track status for lead program Aravive to raise $41.5M in di...
2023-08-03 13:02:58 ET Gainers: Bluejay Diagnostics ( BJDX ) +73% . T2 Biosystems ( TTOO ) +67% . Traeger ( COOK ) +41% . Upwork ( UPWK ) +41% . Adamis Pharmaceuticals Corporation ( ADMP ) +40% . Motorsport Games ( MSGM )...
2023-08-03 10:16:24 ET Gainers: Bluejay Diagnostics ( BJDX ) +74% . Adamis Pharmaceuticals ( ADMP ) +59% . T2 Biosystems ( TTOO ) +47% . Community Health Systems ( CYH ) +18% . Cyclo Therapeutics ( CYTH ) +17% . Losers:...
2023-08-03 09:05:43 ET Aravive ( ARAV ) -58% announces top-line results from phase 3 AXLerate-OC study of batiraxcept in patinum-resistant ovarian cancer. Vicarious Surgical ( RBOT ) -41% on pricing $45M offering . DXC Technology Company ( DXC ) -24% ...
2023-08-03 08:52:55 ET More on Aravive Aravive: Very Small Company With Late Stage Trial In Ovarian Cancer Aravive stock pops on FDA orphan drug status for batiraxcept to treat pancreatic cancer Aravive gains on FDA Fast Track status for lead program Aravive ...
Trial did not meet primary endpoint of progression-free survival Cash at the end of Q2 of approximately $18M (unaudited) is expected to be sufficient to fund operations into early Q4 2023 HOUSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”...
News, Short Squeeze, Breakout and More Instantly...
Aravive Inc. Company Name:
ARAV Stock Symbol:
NASDAQ Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...